Rinvoq
- Product NDC
- 0074-2320
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Upadacitinib
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- AbbVie Inc.
- Application
- NDA218347
- Marketing category
- NDA
- Substance
- UPADACITINIB
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 0074-2320-01 | 1 BOTTLE in 1 CARTON (0074-2320-01) / 180 mL in 1 BOTTLE | 2024-04-26 | | No | Historical |
| 0074-2320-70 | 1 BOTTLE in 1 CARTON (0074-2320-70) / 180 mL in 1 BOTTLE | 2024-04-26 | | Yes | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Rinvoq | AbbVie Inc. | 2025-10-23 | HUMAN PRESCRIPTION DRUG LABEL | 100 |
| Rinvoq | AbbVie Inc. | 2025-04-28 | HUMAN PRESCRIPTION DRUG LABEL | 92 |